Cargando…
Clinical and imaging features of myeloid sarcoma: a German multicenter study
BACKGROUND: Myeloid sarcoma (MS), also known as chloroma, is an extramedullary manifestation of malignant primitive myeloid cells. Previously, only small studies investigated clinical and imaging features of MS. The purpose of this study was to elucidate clinical and imaging features of MS based upo...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6882227/ https://www.ncbi.nlm.nih.gov/pubmed/31775680 http://dx.doi.org/10.1186/s12885-019-6357-y |
_version_ | 1783474110607654912 |
---|---|
author | Meyer, Hans-Jonas Pönisch, Wolfram Schmidt, Stefan Andreas Wienbeck, Susanne Braulke, Friederike Schramm, Dominik Surov, Alexey |
author_facet | Meyer, Hans-Jonas Pönisch, Wolfram Schmidt, Stefan Andreas Wienbeck, Susanne Braulke, Friederike Schramm, Dominik Surov, Alexey |
author_sort | Meyer, Hans-Jonas |
collection | PubMed |
description | BACKGROUND: Myeloid sarcoma (MS), also known as chloroma, is an extramedullary manifestation of malignant primitive myeloid cells. Previously, only small studies investigated clinical and imaging features of MS. The purpose of this study was to elucidate clinical and imaging features of MS based upon a multicenter patient sample. METHODS: Patient records of radiological databases of 4 German university hospitals were retrospectively screened for MS in the time period 01/2001 and 06/2019. Overall, 151 cases/76 females (50.3%) with a mean age of 55.5 ± 15.1 years and 183 histopathological confirmation or clinically suspicious lesions of MS were included into this study. The underlying hematological disease, localizations, and clinical symptoms as well as imaging features on CT and MRI were investigated. RESULTS: In 15 patients (9.9% of all 151 cases) the manifestation of MS preceded the systemic hematological disease. In 43 cases (28.4%), first presentation of MS occurred simultaneously with the initial diagnosis of leukemia, and 92 (60.9%) patients presented MS after the initial diagnosis. In 37 patients (24.5%), the diagnosis was made incidentally by imaging. Clinically, cutaneous lesions were detected in 35 of 151 cases (23.2%). Other leading symptoms were pain (n = 28/151, 18.5%), neurological deficit (n = 27/151, 17.9%), swelling (n = 14/151, 9.3%) and dysfunction of the affected organ (n = 10/151, 6.0%). Most commonly, skin was affected (n = 30/151, 16.6%), followed by bone (n = 29/151, 16.0%) and lymphatic tissue (n = 21/151, 11.4%). Other localizations were rare. On CT, most lesions were homogenous. On T2-weighted imaging, most of the lesions were hyperintense. On T1-weighted images, MS was hypointense in n = 22/54 (40.7%) and isointense in n = 30/54 (55.6%). A diffusion restriction was identified in most cases with a mean ADC value of 0.76 ± 0.19 × 10(− 3) mm(2)/s. CONCLUSIONS: The present study shows clinical and imaging features of MS based upon a large patient sample in a multicenter design. MS occurs in most cases meta-chronous to the hematological disease and most commonly affects the cutis. One fourth of cases were identified incidentally on imaging, which needs awareness of the radiologists for possible diagnosis of MS. |
format | Online Article Text |
id | pubmed-6882227 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-68822272019-12-03 Clinical and imaging features of myeloid sarcoma: a German multicenter study Meyer, Hans-Jonas Pönisch, Wolfram Schmidt, Stefan Andreas Wienbeck, Susanne Braulke, Friederike Schramm, Dominik Surov, Alexey BMC Cancer Research Article BACKGROUND: Myeloid sarcoma (MS), also known as chloroma, is an extramedullary manifestation of malignant primitive myeloid cells. Previously, only small studies investigated clinical and imaging features of MS. The purpose of this study was to elucidate clinical and imaging features of MS based upon a multicenter patient sample. METHODS: Patient records of radiological databases of 4 German university hospitals were retrospectively screened for MS in the time period 01/2001 and 06/2019. Overall, 151 cases/76 females (50.3%) with a mean age of 55.5 ± 15.1 years and 183 histopathological confirmation or clinically suspicious lesions of MS were included into this study. The underlying hematological disease, localizations, and clinical symptoms as well as imaging features on CT and MRI were investigated. RESULTS: In 15 patients (9.9% of all 151 cases) the manifestation of MS preceded the systemic hematological disease. In 43 cases (28.4%), first presentation of MS occurred simultaneously with the initial diagnosis of leukemia, and 92 (60.9%) patients presented MS after the initial diagnosis. In 37 patients (24.5%), the diagnosis was made incidentally by imaging. Clinically, cutaneous lesions were detected in 35 of 151 cases (23.2%). Other leading symptoms were pain (n = 28/151, 18.5%), neurological deficit (n = 27/151, 17.9%), swelling (n = 14/151, 9.3%) and dysfunction of the affected organ (n = 10/151, 6.0%). Most commonly, skin was affected (n = 30/151, 16.6%), followed by bone (n = 29/151, 16.0%) and lymphatic tissue (n = 21/151, 11.4%). Other localizations were rare. On CT, most lesions were homogenous. On T2-weighted imaging, most of the lesions were hyperintense. On T1-weighted images, MS was hypointense in n = 22/54 (40.7%) and isointense in n = 30/54 (55.6%). A diffusion restriction was identified in most cases with a mean ADC value of 0.76 ± 0.19 × 10(− 3) mm(2)/s. CONCLUSIONS: The present study shows clinical and imaging features of MS based upon a large patient sample in a multicenter design. MS occurs in most cases meta-chronous to the hematological disease and most commonly affects the cutis. One fourth of cases were identified incidentally on imaging, which needs awareness of the radiologists for possible diagnosis of MS. BioMed Central 2019-11-27 /pmc/articles/PMC6882227/ /pubmed/31775680 http://dx.doi.org/10.1186/s12885-019-6357-y Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Meyer, Hans-Jonas Pönisch, Wolfram Schmidt, Stefan Andreas Wienbeck, Susanne Braulke, Friederike Schramm, Dominik Surov, Alexey Clinical and imaging features of myeloid sarcoma: a German multicenter study |
title | Clinical and imaging features of myeloid sarcoma: a German multicenter study |
title_full | Clinical and imaging features of myeloid sarcoma: a German multicenter study |
title_fullStr | Clinical and imaging features of myeloid sarcoma: a German multicenter study |
title_full_unstemmed | Clinical and imaging features of myeloid sarcoma: a German multicenter study |
title_short | Clinical and imaging features of myeloid sarcoma: a German multicenter study |
title_sort | clinical and imaging features of myeloid sarcoma: a german multicenter study |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6882227/ https://www.ncbi.nlm.nih.gov/pubmed/31775680 http://dx.doi.org/10.1186/s12885-019-6357-y |
work_keys_str_mv | AT meyerhansjonas clinicalandimagingfeaturesofmyeloidsarcomaagermanmulticenterstudy AT ponischwolfram clinicalandimagingfeaturesofmyeloidsarcomaagermanmulticenterstudy AT schmidtstefanandreas clinicalandimagingfeaturesofmyeloidsarcomaagermanmulticenterstudy AT wienbecksusanne clinicalandimagingfeaturesofmyeloidsarcomaagermanmulticenterstudy AT braulkefriederike clinicalandimagingfeaturesofmyeloidsarcomaagermanmulticenterstudy AT schrammdominik clinicalandimagingfeaturesofmyeloidsarcomaagermanmulticenterstudy AT surovalexey clinicalandimagingfeaturesofmyeloidsarcomaagermanmulticenterstudy |